Tobias Zrzavy

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Journal: Journal of neurology

Published: March 09, 2026

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

Journal: Frontiers in neurology

Published: February 25, 2026

Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis.

Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: October 01, 2025

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.

Journal: Neurology

Published: September 29, 2025

Tick-borne infections in patients under anti-CD20 therapy: Challenges for diagnosis and treatment.

Tick-borne infections in patients under anti-CD20 therapy: Challenges for diagnosis and treatment.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 11, 2025

Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.

Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 20, 2025

Engineering Peptide Modulators for T-Cell Migration by Structural Scaffold Matching.

Engineering Peptide Modulators for T-Cell Migration by Structural Scaffold Matching.

Journal: Journal of medicinal chemistry

Published: August 12, 2025

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Journal: Journal of neurology

Published: July 04, 2025

Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis.

Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis.

Journal: Frontiers in immunology

Published: July 02, 2025

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis.

The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis.

Journal: Annals of clinical and translational neurology

Published: June 09, 2025

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center.

The Value of Oligoclonal Bands in Multiple Sclerosis Compared to Other Neurological Disorders: A Retrospective Data Analysis From an Austrian Tertiary Center.

Journal: European journal of neurology

Published: May 27, 2025

Paediatric cerebrospinal fluid immune profiling distinguishes paediatric-onset multiple sclerosis from other paediatric-onset acute neurological disorders.

Paediatric cerebrospinal fluid immune profiling distinguishes paediatric-onset multiple sclerosis from other paediatric-onset acute neurological disorders.

Journal: EBioMedicine

Published: May 09, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026